Endocrine Abstracts

Introduction: In 2013 Trouillas et al. reported a new prognostic clinicopathological classification of pituitary adenomas. This classification analyses the impact of the intensity of proliferation and invasiveness of the tumor on patients’ prognosis. The aim of the study was to review this new classification in giant pituitary adenomas (GPAs) treated with endoscopic transsphenoidal approach.Material and methods: The study is a retrospective...

Introduction: Giant pituitary adenomas (GPAs) are traditionally defined as the tumors with the greatest diameter at or above 40 mm. However, some clinical series of GPAs include tumors with maximal diameter of 35 to 40 mm, and those tumors can be named ‘nearly giant’ pituitary adenomas (nearly GPAs). The treatment of GPAs is challenging and has a higher risk of complications due to the size and complex anatomical relations. This study was conducted to compare GPAs an...

Background: Transsphenoidal adenomectomy of GH-secreting pituitary tumour is a first-line treatment of acromegaly. Pharmacological treatment is recommended if surgery did not lead to disease remission. Pathological assessment of postoperative tissue provides clinicians with valuable information on the disease course.Aim: The aim of this study was to assess whether clinical, imaging, and pathological characteristics can predict surgical remission and resp...